Information  X 
Enter a valid email address

Clarion Funding plc (96XN)

  Print      Mail a friend

Monday 02 September, 2019

Clarion Funding plc

Doro Group acquires Invicta Telecare Ltd

RNS Number : 7663K
Clarion Funding plc
02 September 2019
 

Clarion Funding plc

2nd September 2019

Doro Group acquires Invicta Telecare Ltd from Clarion Housing Group

Clarion Housing Group announces that Doro Group has acquired Invicta Telecare Ltd, known as Centra Pulse & Connect, from Circle Care and Support Limited. Circle Care and Support Limited is a direct subsidiary of Clarion Housing Group Ltd.

Centra Pulse and Connect is a telecare business, with revenues of £6.3million in the last financial year. This accounts for less than 1% of the turnover of Clarion Housing Group.

Michelle Reynolds, Chief Operating Officer at Clarion Housing Group commented:

"Clarion made the decision to sell Invicta Telecare Ltd because we believe that Doro Group is better placed to meet the long-term needs of these customers. As a specialist technology company, Doro Group has capacity to invest and innovate in the telecare market, providing a first class product to support independent living in older age.

As the largest social landlord in the country, our focus at Clarion will continue to be on building homes, creating communities and providing for people who are failed by the housing market."

Ends

For further information, please contact:

Gareth Francis, Director of Treasury and Corporate Finance

Clarion Housing Group Limited

Level 6, 6 More London Place, Tooley Street, London SE1 2DA

Telephone:      020 7378 5526

Email: [email protected]

Andrew Lewin, Head of Corporate Communications

Clarion Housing Group Limited

Level 6, 6 More London Place, Tooley Street, London SE1 2DA

Telephone:      07969731501

Email: [email protected] / [email protected]

 

 


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.
 
END
 
 
MSCPMMITMBBJBML

a d v e r t i s e m e n t